Phase 3 Readout~month

Phase 3 Topline: Phase 3 Study to Evaluate the Safety and Efficacy of AAV5-hRKp.RPGR for the Treatment of Japanese X-

Indication
Retinitis Pigmentosa

Other upcoming events for REPL

Phase 2 StartPhase 2 Start: A Phase 2 Study of RP2 With Tivozanib in Patients With Metastatic Renal Carcinoma After Progression
Phase 3 ReadoutPhase 3 Topline: A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combinati
Phase 3 ReadoutPhase 3 Topline: Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs
Patent ExpiryPatent/Exclusivity Expiry: FOTIVDA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Phase 3 Study to Evaluate the Safety and Efficacy of AAV5-hRKp.RPGR for the Treatment of Japanese X- — REPL Phase 3 Readout | BioSniper